FOLH1 and posterior cortical atrophy: Since then, we have conducted more than 5000 PSMA PET examinations for patients with primary PCa, as well for patients with biochemical recurrent PCa and patients with metastatic hormone-sensitive (mHSPC) and castration-resistant PCa (mCRPC) [7,8,9,10].